These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 11693183)
1. Quantitative proteomic analysis of mouse liver response to the peroxisome proliferator diethylhexylphthalate (DEHP). Macdonald N; Chevalier S; Tonge R; Davison M; Rowlinson R; Young J; Rayner S; Roberts R Arch Toxicol; 2001 Sep; 75(7):415-24. PubMed ID: 11693183 [TBL] [Abstract][Full Text] [Related]
2. Suppression of mouse hepatocyte apoptosis by peroxisome proliferators: role of PPARalpha and TNFalpha. Hasmall SC; James NH; Macdonald N; Gonzalez FJ; Peters JM; Roberts RA Mutat Res; 2000 Mar; 448(2):193-200. PubMed ID: 10725472 [TBL] [Abstract][Full Text] [Related]
3. Characterization of peroxisome proliferator-activated receptor alpha--independent effects of PPARalpha activators in the rodent liver: di-(2-ethylhexyl) phthalate also activates the constitutive-activated receptor. Ren H; Aleksunes LM; Wood C; Vallanat B; George MH; Klaassen CD; Corton JC Toxicol Sci; 2010 Jan; 113(1):45-59. PubMed ID: 19850644 [TBL] [Abstract][Full Text] [Related]
4. Species differences in response to diethylhexylphthalate: suppression of apoptosis, induction of DNA synthesis and peroxisome proliferator activated receptor alpha-mediated gene expression. Hasmall SC; James NH; Macdonald N; Soames AR; Roberts RA Arch Toxicol; 2000 Apr; 74(2):85-91. PubMed ID: 10839475 [TBL] [Abstract][Full Text] [Related]
5. Mouse hepatocyte response to peroxisome proliferators: dependency on hepatic nonparenchymal cells and peroxisome proliferator activated receptor alpha (PPARalpha). Hasmall S; James N; Hedley K; Olsen K; Roberts R Arch Toxicol; 2001 Aug; 75(6):357-61. PubMed ID: 11570693 [TBL] [Abstract][Full Text] [Related]
6. Downregulation of lactoferrin by PPARalpha ligands: role in perturbation of hepatocyte proliferation and apoptosis. Hasmall S; Orphanides G; James N; Pennie W; Hedley K; Soames A; Kimber I; Roberts R Toxicol Sci; 2002 Aug; 68(2):304-13. PubMed ID: 12151626 [TBL] [Abstract][Full Text] [Related]
7. Peroxisome proliferators: mechanisms of adverse effects in rodents and molecular basis for species differences. Roberts RA Arch Toxicol; 1999 Nov; 73(8-9):413-8. PubMed ID: 10650911 [TBL] [Abstract][Full Text] [Related]
8. PPARalpha-dependent alteration of GRP94 expression in mouse hepatocytes. Macdonald N; Barrow K; Tonge R; Davison M; Roberts RA; Chevalier S Biochem Biophys Res Commun; 2000 Nov; 277(3):699-704. PubMed ID: 11062016 [TBL] [Abstract][Full Text] [Related]
9. Hydrogen peroxide generation in peroxisome proliferator-induced oncogenesis. Yeldandi AV; Rao MS; Reddy JK Mutat Res; 2000 Mar; 448(2):159-77. PubMed ID: 10725470 [TBL] [Abstract][Full Text] [Related]
10. Apoptosis and proliferation in nongenotoxic carcinogenesis: species differences and role of PPARalpha. Roberts RA; James NH; Hasmall SC; Holden PR; Lambe K; Macdonald N; West D; Woodyatt NJ; Whitcome D Toxicol Lett; 2000 Mar; 112-113():49-57. PubMed ID: 10720712 [TBL] [Abstract][Full Text] [Related]
11. Is peroxisome proliferation an obligatory precursor step in the carcinogenicity of di(2-ethylhexyl)phthalate (DEHP)? Melnick RL Environ Health Perspect; 2001 May; 109(5):437-42. PubMed ID: 11401753 [TBL] [Abstract][Full Text] [Related]
12. Elevated basal expression of liver peroxisomal beta-oxidation enzymes and CYP4A microsomal fatty acid omega-hydroxylase in STAT5b(-/-) mice: cross-talk in vivo between peroxisome proliferator-activated receptor and signal transducer and activator of transcription signaling pathways. Zhou YC; Davey HW; McLachlan MJ; Xie T; Waxman DJ Toxicol Appl Pharmacol; 2002 Jul; 182(1):1-10. PubMed ID: 12127257 [TBL] [Abstract][Full Text] [Related]
13. A cancer risk assessment of di(2-ethylhexyl)phthalate: application of the new U.S. EPA Risk Assessment Guidelines. Doull J; Cattley R; Elcombe C; Lake BG; Swenberg J; Wilkinson C; Williams G; van Gemert M Regul Toxicol Pharmacol; 1999 Jun; 29(3):327-57. PubMed ID: 10388618 [TBL] [Abstract][Full Text] [Related]
14. Weight-of-evidence versus strength-of-evidence in toxicologic hazard identification: Di(2-ethylhexyl)phthalate (DEHP). Willhite CC Toxicology; 2001 Mar; 160(1-3):219-26. PubMed ID: 11246142 [TBL] [Abstract][Full Text] [Related]
15. Hepatic expression of acute-phase protein genes during carcinogenesis induced by peroxisome proliferators. Anderson SP; Cattley RC; Corton JC Mol Carcinog; 1999 Dec; 26(4):226-38. PubMed ID: 10569800 [TBL] [Abstract][Full Text] [Related]
16. Involvement of the peroxisome proliferator-activated receptor alpha in the immunomodulation caused by peroxisome proliferators in mice. Yang Q; Xie Y; Alexson SE; Nelson BD; DePierre JW Biochem Pharmacol; 2002 May; 63(10):1893-900. PubMed ID: 12034374 [TBL] [Abstract][Full Text] [Related]
17. Peroxisomal and mitochondrial fatty acid beta-oxidation in mice nullizygous for both peroxisome proliferator-activated receptor alpha and peroxisomal fatty acyl-CoA oxidase. Genotype correlation with fatty liver phenotype. Hashimoto T; Fujita T; Usuda N; Cook W; Qi C; Peters JM; Gonzalez FJ; Yeldandi AV; Rao MS; Reddy JK J Biol Chem; 1999 Jul; 274(27):19228-36. PubMed ID: 10383430 [TBL] [Abstract][Full Text] [Related]